Purpose This study investigated the pattern of recurrence of lung adenocarcinoma and the
predictive value of histologic classification in resected lung adenocarcinoma using the new …

BACKGROUND: Patients with stage I–II non-small cell lung cancer (NSCLC) show variability
in recurrence after curative resection. Several factors have been proposed as prognostic of …

Objective: Positron emission tomography has proven to be an invaluable tool for diagnosing
and staging non-small cell lung cancer. The authors analyzed relationships between the …

The current recommended imaging required for lung cancer staging is CT of the thorax and
PET/CT from skull base to mid-thigh. However, with the recent developments in the …

Integrated positron emission tomography (PET) and computed tomography (CT) is a new
imaging modality offering anatomic and metabolic information. The purpose was to evaluate …

Purpose Primary lung cancers have varying prognoses, even for tumors≤ 3 cm in diameter.
Thus, a thorough evaluation is necessary for therapeutic planning. Two imaging biomarkers …

Introduction The new grading system proposed by the Pathology Committee of the
International Association for the Study of Lung Cancer in 2020 was based on the …

Positron emission tomography/computed tomography (PET/CT) is an important imaging tool
for management of lung cancer and can be utilized in diagnosis, staging, restaging …

AIM: To determine the relationship between the metabolic activity measured by 2-[18F]-
fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET) and computed …

In the past 10 years, positron emission tomography (PET), usually with 18 F-fluoro-2-deoxy-
D-glucose (FDG), has become an important imaging modality in patients with lung cancer …